225430 — KMPharmaceutical Co Income Statement

0.000.00%

Last trade - 00:00

Consumer DefensivesAdventurousMicro CapSucker Stock

Annual income statement for KMPharmaceutical Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	R2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	20,338	22,928	22,705	15,631	17,770
Cost of Revenue
Gross Profit	5,786	5,941	5,663	3,225	4,910
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses	21,864	22,216	22,341	17,686	18,869
Operating Profit	-1,526	712	364	-2,055	-1,100
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	-1,262	322	-514	-4,574	-964
Provision for Income Taxes
Net Income After Taxes	-902	471	-611	-3,925	-1,320
Net Income Before Extraordinary Items
Net Income	-902	471	-611	-3,925	-1,320
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Dilution Adjustment
Diluted Net Income	-902	471	-611	-3,925	-1,320
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	-41	21.8	-10.4	-122	-47.4
Dividends per Share